Ocular Therapeutix, Inc. (OCUL)
9.495
+0.26
(+2.76%)
USD |
NASDAQ |
May 14, 16:00
9.47
-0.02
(-0.26%)
After-Hours: 19:55
Ocular Therapeutix Total Assets (Quarterly) : 732.53M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| EyePoint, Inc. | 288.22M |
| Merck & Co., Inc. | 128.68B |
| Zevra Therapeutics, Inc. | 278.58M |
| Axsome Therapeutics, Inc. | 713.61M |
| Bristol Myers Squibb Co. | 86.48B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 150.96M |
| Shareholders Equity (Quarterly) | 581.57M |
| Debt to Equity Ratio | 0.1366 |
| Current Ratio | 14.81 |
| Net Debt Paydown Yield | -0.04% |